THE GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE WAS VALUED AT USD 535 MILLION IN 2021 AND IS EXPECTED TO REACH USD 5,724.45 MILLION BY 2027, GROWING AT A CAGR OF 48.44% DURING THE FORECAST PERIOD

Artificial Intelligence In Genomics Market Size, Share, Growth Analysis, Forecast By

  • Delivery Mode: On-Premises And Cloud-Based
  • Functionality: Genome Sequencing, Gene Editing, And Others
  • Application: Translational Precision Medicine, Clinical & Genomic Diagnostics, And Others
  • End-User: Pharma & Biotech Companies, Public & Consumer Genomic Centers, And Others

Global Industry Analysis, Market Share, Regional Outlook, Revenue Opportunity Forecast 2022-2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

265 Pages

icon-table

149 Tables

icon-chart

107 Charts

icon-region

5 Regions

icon-country

17 Countries

icon-company

22 Companies

icon-market

5 Market Segment

ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 5,724.45 MILLION (2027)
CAGR 48.44% (2022-2027)
BASE YEAR 2021
FORECAST YEAR 2022-2027
MARKET SEGMENTS Delivery Mode (On-Premises and Cloud-Based), Functionality (Genome Sequencing, Gene Editing, and Others), Application (Translational Precision Medicine, Clinical & Genomic Diagostics, and Others), End User (Pharma & Biotech Companies, Public & Consumer Genomic Centers, and Others)
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, Middle East & Africa
COUNTRIES COVERED US, Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Turkey, Saudi Arabia, and South Africa

MARKET INSIGHTS

The global AI in genomics market was valued at USD 535 million in 2021 and is expected to reach USD 5,724.45 million by 2027, growing at a CAGR of 48.44% from 2022 to 2027. Artificial intelligence (AI) is the development of computer systems that are able to perform tasks that normally require human intelligence. A genomics-driven approach could improve understanding of disease biology, create a significant change in R&D costs and efficiency, and bring more targeted drugs to patients sooner. Artificial intelligence in drug discovery can make its development speedier and less hazardous, making it easy for clinicians to understand complicated diseases at the genetic level. The emergence of new and favorable applications for disease diagnosis and monitoring is expected to drive the AI in genomics market growth further. Several genomic-focused companies have shown favorable returns.

Ever since the Human Genome Project began in 1990, genomics has shown a massive opportunity to enhance and personalize healthcare. Top healthcare investors, including Sequoia Capital and Deerfield Management, are acknowledging that this data has unlocked considerable commercial opportunities across healthcare verticals.

KEY INSIGHTS

  • In 2017, liquid biopsy company GRAIL raised an unprecedented USD 914 million in its Series B round led by Smart Money VC ARCH Venture Partners and including Johnson & Johnson to continue product development and validation for its early-stage cancer detection blood test.
  • Another company that is making a lot of noise in the data-driven medicine space is Sophia Genetics from Switzerland. It already works with a half-dozen UK hospitals to pool data and bring AI-driven insights to cancer diagnostics, claiming to already diagnose hundreds of patients a day.

WHAT ARE NETIZENS SAYING ABOUT AI IN GENOMICS?

The genomics industry needs to expand its use of computational methods such as AI / ML to understand better the complex and hidden patterns in genomics data sets from clinical research projects. Personalized medicine treatment is a complex and challenging process in healthcare. Many barriers, such as capturing, analyzing, and leveraging patient genomics data, can overshadow it.

The DNA data of organisms is referred to as genomic data. When combined with clinical, pharmaceutical, and lifestyle information, genomic data can assist providers in detecting early signs and symptoms of disease or determining an individual patient's risk of developing the disease. Genomics can reveal the underlying causes of clinical changes, paving the way for more personalized, effective treatments.

However, this information is complex, and the field of genomics is rapidly evolving. Providing precise, understandable genomic data to clinicians at the point of care remains a significant challenge for many healthcare systems. As the industry struggles to make sense of genomic data and incorporate it into routine clinical care, researchers and organizations increasingly turn to artificial intelligence to extract actionable insights from genomic data.

The perfect match of AI and genomics will make precision medicine a reality. By analyzing and converting genomic data into actionable meaningful clinical information, AI will be the key to improving the interpretability of genomic data.

The AI's meaningful interpretation of raw genomics data will improve disease diagnosis, understanding of what medications should be given and to whom, minimizing side effects, and maximizing efficacy. Researchers at pharmaceutical companies are using AI / ML models and genomic data to discover more about incurable and common diseases. Understanding how these conditions differ between individuals can lead to more personalized treatments, and advanced analytics can assist the top industries in getting there. READ MORE...

 

ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SEGMENTATION

  • The on-premises segment accounted for a share of more than 60% of the global artificial intelligence in genomics market in 2021. This is primarily attributed to the broad range of advantages associated with the use of on-premises software, such as high security of data, low risk of data breaches, and full command over software upgrades & data storage.
  • The closer combination of AI and gene sequencing will help in the development of the genome sequencing market. Companies such as Deep Genomics, use machine learning to support researchers interpret genetic variation.
  • The translational precision medicine software market held the largest share in application segmentation. The traditional approach of drug discovery is changing. This paradigm shift comes with a requirement for both precision and translation, leading to a modern Translational Precision Medicine approach to drug discovery and development.
  • Data has always been key to drug development. The need to refill pipelines in a cost-efficient manner forced innovative pharma to look for faster, more efficient ways of identifying drug candidates. For instance, Pfizer has used a machine learning system called IBM Watson to search for cancer drug targets. All of these factors are leading Pharma and Biotech companies to be the biggest end-users in the genomics industry.

REGIONAL INSIGHTS

North America: North America accounted for more than half of the global artificial intelligence in genomics market share in 2021. The AI in genomics market is likely to increase in North America owing to the growing adoption of AI in genome sequencing and rising awareness among the regional pharma and biotech companies. AI deep learning algorithms have also saved many lives in North America by reducing the diagnosis-treatment-recovery cycle for patients.

Europe: The increased awareness among European patients drives the application of personal genome sequencing testing, especially for reproductive health. Artificial Intelligence (AI) is widely helping in diagnostics and contributing to accessible, affordable, and good quality healthcare, which is consequently improving accuracy.

KEY COMPANIES & MARKET INSIGHTS

  • The key players in artificial intelligence in genomics market are Fabric Genomics, International Business Machines, Microsoft, and
  • Vendors are increasingly focusing on launching innovative devices to penetrate and tap the huge growth potential prevailing in the market.
  • WuXi NextCODE has raised USD 455 million in disclosed equity funding, involving a USD 200 million Series C led by Ireland Strategic Investment Fund in November 2018.
  • AI in life sciences R&D start-ups have raised a total of USD 10 billion from 2015 to the first half of 2021. The Toronto-based start-up, which was founded in 2014, has raised a combined USD 3.7 million in seed financing from three US venture capital companies.

The artificial intelligence in genomics market report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Delivery Mode

  • On-Premises
  • Cloud-Based

Segmentation by Functionality

  • Genome Sequencing
  • Gene Editing
  • Others

Segmentation by Application

  • Translational Precision Medicine
  • Clinical & Genomic Diagnostics
  • Others

Segmentation by End User

  • Pharma & Biotech Companies
  • Public & Consumer Genomic Centers
  • Others

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

This Report Addresses:

  • Market research and successful decision making
  • Market forecasts from 2022 to 2027
  • Growth opportunities and trend analysis
  • Segments and regional insights
  • Key companies and market share analysis

Frequently Asked Questions

What is the forecasted value of global Artificial Intelligence in genomics market size in 2027?

The global artificial intelligence in genomics market is expected to reach USD 5,724.45 million by 2027.

What factors will drive Artificial Intelligence (AI) in genomics market?

The factors that will drive Artificial Intelligence in genomics market are rising investments by government and venture capital firms, the emergence of local and regional start-ups, collaborations of pharmaceutical and software companies, etc.

Who are the key players in Artificial Intelligence in genomics market?

The key players in Artificial Intelligence in genomics market are Fabric Genomics, International Business Machines, Microsoft, and NVIDIA

What is the post-pandemic scenario of the Artificial Intelligence in genomics market?

In the last couple of years, there has been a remarkable upsurge in the investment in genomics companies, as the start-ups are seeking to improve genetic data diversity. The demand for COVID-19 genetic tests has further enhanced the funding trend in the AI genomics market.

What are some new product launches that created a buzz in the market?

Announcements of new AI deals, partnerships, and product launches in biopharma are coming at a rapid pace. Genomenon, an AI-driven genomics company, recently announced a proof-of-concept agreement with Deep 6 AI, an AI-based clinical trial acceleration software company.

Download Free Sample

The artificial intelligence in genomics market size was valued at USD 535 million in 2021 and is expected to reach USD 5,724.45 million by 2027, growing at a CAGR of 48.44% during the forecast period

The following factors are likely to contribute to the growth of artificial intelligence in genomics market-

  • Rising Investment by Government & Private Players in Genomics
  • Emergence of Local and Regional Start-ups
  • Emergence of Local and Regional Start-ups
  • Rising Adoption of Machine Learning in Personalized/Precision Medicine
  • Rising Focus on Reducing the Turnaround Time in Drugs Discovery & Diagnostics

BASE YEAR: 2021

FORECAST YEAR: 2022-2027

Key Vendors

  • Fabric Genomics
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • International Business Machines
  • Microsoft
  • NVIDIA

Other Prominent Vendors

  • AI Therapeutics
    • Business Overview
    • Product Offerings
  • Ares Genetics
  • BenevolentAI
  • Deep Genomics
  • Diploid
  • DNAnexus
  • Emedgene
  • Empiric Logic
  • Engine Biosciences
  • FDNA
  • Freenome Holdings
  • Genuity Science
  • Lifebit
  • MolecularMatch
  • Predictive Oncology
  • SOPHiA GENETICS
  • Verge Genomics
  • WhiteLab Genomics

Market Segmentation by Delivery Mode

  • On-Premises
  • Cloud-Based

Market Segmentation by Functionality

  • Genome Sequencing
  • Gene Editing
  • Others

Market Segmentation by Application

  • Translational Precision Medicine
  • Clinical & Genomic Diagnostics
  • Others

Market Segmentation by End User

  • Pharma & Biotech Companies
  • Public & Consumer Genomic Centers
  • Others

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS

4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Delivery Mode
4.3.2 Market Segmentation by Functionality
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by End-User
4.3.5 Market Segmentation by Geography

5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 AI in Healthcare
7.2 AI in Genomics

8 MARKET OPPORTUNITIES & TRENDS
8.1 Investments by Government & Private Players
8.2 Emergence of Local and Regional Start-Ups
8.3 Collaborations of Pharmaceutical and Software Companies
8.4 Rising Adoption of MI in Personalized/Precision Medicine

9 MARKET GROWTH ENABLERS
9.1 Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics
9.2 Growing Adoption of AI-Based Solutions
9.3 Increased Biomedical and Genomic Datasets

10 MARKET RESTRAINTS
10.1 Lack of Skilled Workforce & Infrastructure
10.2 Ambiguous Regulatory Guidelines for Genomics Software
10.3 Poor Security & Storage of Large Volumes of Genome Sequencing Data

11 MARKET LANDSCAPE
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Geographic Insights
11.2.2 Delivery Mode Insights
11.2.3 Functionality Insights
11.2.4 Application Insights
11.2.5 End-User Insights
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry

12 DELIVERY MODE
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 On-Premises
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Market by Geography
12.4 Cloud-Based
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Market by Geography

13 FUNCTIONALITY
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Genome Sequencing
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market by Geography
13.4 Gene Editing
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market by Geography
13.5 Others
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market by Geography

14 APPLICATION
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Translational Precision Medicine
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market by Geography
14.4 Clinical & Genomic Diagnosis
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market by Geography
14.5 Other Applications
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Market by Geography

15 END-USER
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Pharma & Biotech Companies
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Market by Geography
15.4 Public & Consumer Genomic Centers
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Market by Geography
15.5 Others
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Market by Geography

16 GEOGRAPHY
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview

17 NORTH AMERICA
17.1 Market Overview
17.2 Market Size & Forecast
17.3 North America: Delivery Mode
17.3.1 Market Size & Forecast
17.4 North America: Functionality
17.4.1 Market Size & Forecast
17.5 North America: Application
17.5.1 Market Size & Forecast
17.6 North America: End-User
17.6.1 Market Size & Forecast
17.7 Key Countries
17.7.1 US: Market Size & Forecast
17.7.2 Canada: Market Size & Forecast

18 EUROPE
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Europe: Delivery Mode
18.3.1 Market Size & Forecast
18.4 Europe: Functionality
18.4.1 Market Size & Forecast
18.5 Europe: Application
18.5.1 Market Size & Forecast
18.6 Europe: End-User
18.6.1 Market Size & Forecast
18.7 Key Countries
18.7.1 Germany: Market Size & Forecast
18.7.2 UK: Market Size & Forecast
18.7.3 France: Market Size & Forecast
18.7.4 Italy: Market Size & Forecast
18.7.5 Spain: Market Size & Forecast

19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 APAC: Delivery Mode
19.3.1 Market Size & Forecast
19.4 APAC: Functionality
19.4.1 Market Size & Forecast
19.5 APAC: Application
19.5.1 Market Size & Forecast
19.6 APAC: End-User
19.6.1 Market Size & Forecast
19.7 Key Countries
19.7.1 Japan: Market Size & Forecast
19.7.2 China: Market Size & Forecast
19.7.3 India: Market Size & Forecast
19.7.4 Australia: Market Size & Forecast
19.7.5 South Korea: Market Size & Forecast

20 LATIN AMERICA
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Latin America: Delivery Mode
20.3.1 Market Size & Forecast
20.4 Latin America: Functionality
20.4.1 Market Size & Forecast
20.5 Latin America: Application
20.5.1 Market Size & Forecast
20.6 Latin America: End-User
20.6.1 Market Size & Forecast
20.7 Key Countries
20.7.1 Brazil: Market Size & Forecast
20.7.2 Mexico: Market Size & Forecast

21 MIDDLE EAST & AFRICA
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Middle East & Africa: Delivery Mode
21.3.1 Market Size & Forecast
21.4 Middle East & Africa: Functionality
21.4.1 Market Size & Forecast
21.5 Middle East & Africa: Application
21.5.1 Market Size & Forecast
21.6 Middle East & Africa: End-User
21.6.1 Market Size & Forecast
21.7 Key Countries
21.7.1 Turkey: Market Size & Forecast
21.7.2 Saudi Arabia: Market Size & Forecast
21.7.3 South Africa: Market Size & Forecast

22 COMPETITIVE LANDSCAPE
22.1 Competition Overview

23 KEY COMPANY PROFILES

23.1 FABRIC GENOMICS
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities

23.2 INTERNATIONAL BUSINESS MACHINES
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities

23.3 MICROSOFT
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities

23.4 NVIDIA
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities

24 OTHER PROMINENT VENDORS

24.1 AI THERAPEUTICS
24.1.1 Business Overview
24.1.2 Product Offerings

24.2 ARES GENETICS
24.2.1 Business Overview
24.2.2 Product Offerings

24.3 BENEVOLENTAI
24.3.1 Business Overview
24.3.2 Product Offerings

24.4 DEEP GENOMICS
24.4.1 Business Overview
24.4.1 Product Offerings

24.5 DIPLOID
24.5.1 Business Overview
24.5.2 Product Offerings

24.6 DNANEXUS
24.6.1 Business Overview
24.6.2 Product Offerings

24.7 EMEDGENE
24.7.1 Business Overview
24.7.2 Product Offerings

24.8 EMPIRIC LOGIC
24.8.1 Business Overview
24.8.2 Product Offerings

24.9 ENGINE BIOSCIENCES
24.9.1 Business Overview
24.9.2 Product Offerings

24.10 FDNA
24.10.1 Business Overview
24.10.2 Product Offerings

24.11 FREENOME HOLDINGS
24.11.1 Business Overview
24.11.2 Product Offerings

24.12 GENUITY SCIENCE
24.12.1 Business Overview
24.12.2 Product Offerings

24.13 LIFEBIT
24.13.1 Business Overview
24.13.2 Product Offerings

24.14 MOLECULARMATCH
24.14.1 Business Overview
24.14.2 Product Offerings

24.15 PREDICTIVE ONCOLOGY
24.15.1 Business Overview
24.15.2 Product Offerings

24.16 SOPHIA GENETICS
24.16.1 Business Overview
24.16.2 Product Offerings

24.17 VERGE GENOMICS
24.17.1 Business Overview
24.17.2 Product Offerings

24.18 WHITELAB GENOMICS
24.18.1 Business Overview
24.18.2 Product Offerings

25 REPORT SUMMARY
25.1 Key Takeaways
25.2 Strategic Recommendations

26 QUANTITATIVE SUMMARY
26.1 Geography
26.1.1 North America: Delivery Mode
26.1.2 North America: Functionality
26.1.3 North America: Application
26.1.4 North America: End-User
26.1.5 Europe: Delivery Mode
26.1.6 Europe: Functionality
26.1.7 Europe: Application
26.1.8 Europe: End-User
26.1.9 APAC: Delivery Mode
26.1.10 APAC: Functionality
26.1.11 APAC: Application
26.1.12 APAC: End-User
26.1.13 Latin America: Delivery Mode
26.1.14 Latin America: Functionality
26.1.15 Latin America: Application
26.1.16 Latin America: End-User
26.1.17 Middle East & Africa: Delivery Mode
26.1.18 Middle East & Africa: Functionality
26.1.19 Middle East & Africa: Application
26.1.20 Middle East & Africa: End-User
26.2 Delivery Mode
26.2.1 On-Premises
26.2.2 Cloud-Based
26.3 Functionality
26.3.1 Genome Sequencing
26.3.2 Gene Editing
26.3.3 Others
26.4 Application
26.4.1 Translational Precision Medicine
26.4.2 Clinical & Genomic Diagnostics
26.4.3 Other Applications
26.5 End-User
26.5.1 Pharma & Biotech Companies
26.5.2 Public & Consumer Genomic Centers
26.5.3 Others

27 APPENDIX
27.1 Abbreviations

LIST OF EXHIBITS
Exhibit 1 Segmentation of Global AI in Genomics Market
Exhibit 2 Market Size Calculation Approach 2021
Exhibit 3 Impact of Investments by Government & Private Players
Exhibit 4 Impact of Emergence of Local and Regional Start-ups
Exhibit 5 Impact of Collaborations of Pharmaceutical and Software Companies
Exhibit 6 Impact of Rising Adoption of ML in Personalized/Precision Medicine
Exhibit 7 Impact of Rising Focus on Reducing Turnaround Time in Drugs Discovery & Diagnostics
Exhibit 8 Impact of Growing Adoption of AI-Based Solutions
Exhibit 9 Impact of Increased Biomedical and Genomic Datasets
Exhibit 10 Impact of Lack of Skilled Workforce & Infrastructure
Exhibit 11 Impact of Ambiguous Regulatory Guideline for Genomics Software
Exhibit 12 Impact of Poor Security & Storage of Larges Volume of Genome Sequencing Data
Exhibit 13 Global AI in Genomics Market 2021–2027 ($ million)
Exhibit 14 Global AI in Genomics Market by Geography
Exhibit 15 Global AI in Genomics Market by Delivery Mode
Exhibit 16 Global AI in Genomics Market by Functionality
Exhibit 17 Global AI in Genomics Market by Application
Exhibit 18 Global AI in Genomics Market by End-User
Exhibit 19 Five Forces Analysis 2021
Exhibit 20 Incremental Growth by Delivery Mode 2021 & 2027
Exhibit 21 Global AI in Genomics Market by Delivery Mode
Exhibit 22 Global AI in Genomics Market by Delivery Mode: Incremental Growth
Exhibit 23 Global AI in Genomics Market by Delivery Mode: Absolute Growth
Exhibit 24 Global AI in Genomics Market by On-Premises: Incremental & Absolute Growth
Exhibit 25 Global On-Premises AI in Genomics Market 2021–2027 ($ million)
Exhibit 26 Advantages of Implementing Cloud Computing
Exhibit 27 Global Cloud-Based AI in Genomics Market: Incremental & Absolute Growth
Exhibit 28 Global Cloud-Based AI in Genomics Market 2021–2027 ($ million)
Exhibit 29 Incremental Growth by Functionality 2021 & 2027
Exhibit 30 Global AI in Genomics Market by Functionality
Exhibit 31 Global AI in Genomics Market by Functionality: Incremental Growth
Exhibit 32 Global AI in Genomics Market by Functionality: Absolute Growth
Exhibit 33 Global AI in Genomics Market by Genome Sequencing: Incremental & Absolute Growth
Exhibit 34 Global AI in Genomics Market by Genome Sequencing 2021–2027 ($ million)
Exhibit 35 Global AI in Genome Editing Market: Incremental & Absolute Growth
Exhibit 36 Global AI in Genomics Market by Gene Editing 2021–2027 ($ million)
Exhibit 37 Global AI in Genomics Market by Other Functionality: Incremental & Absolute Growth
Exhibit 38 Global AI in Genomics Market by Other Functionality 2021–2027 ($ million)
Exhibit 39 Incremental Growth by Application 2021 & 2027
Exhibit 40 Global AI in Genomics Market by Application
Exhibit 41 Global AI in Genomics Market by Application: Incremental Growth
Exhibit 42 Global AI in Genomics Market by Application: Absolute Growth
Exhibit 43 Vital Components in Translational Precision Medicine
Exhibit 44 Global AI in Genomics Market by Translational Precision Medicine: Incremental & Absolute Growth
Exhibit 45 Global AI in Genomics Market by Application: Translational Precision Medicine 2021–2027 ($ million)
Exhibit 46 Global AI in Genomics Market by Clinical & Genomic Diagnosis: Incremental & Absolute Growth
Exhibit 47 Global AI in Genomics Market by Clinical & Genomic Diagnosis 2021–2027 ($ million)
Exhibit 48 Global AI in Genomics Market by Other Applications: Incremental & Absolute Growth
Exhibit 49 Global AI in Genomics Market by Other Applications 2021–2027 ($ million)
Exhibit 50 Incremental Growth by End-User 2021 & 2027
Exhibit 51 Global AI in Genomics Market by End-User
Exhibit 52 Global AI in Genomics Market by End-User: Incremental Growth
Exhibit 53 Global AI in Genomics Market by End-User: Absolute Growth
Exhibit 54 Global AI in Genomics Market by Pharma & Biotech Companies: Incremental & Absolute Growth
Exhibit 55 Global AI in Genomics Market by Pharma & Biotech Companies 2021–2027 ($ million)
Exhibit 56 Global AI in Genomics Market by Public & Consumer Genomic Centers: Incremental & Absolute Growth
Exhibit 57 Global AI in Genomics Market by Public & Consumer Genomic Centers 2021–2027 ($ million)
Exhibit 58 Global AI in Genomics Market by Other End-Users: Incremental & Absolute Growth
Exhibit 59 Global AI in Genomics Market by Other End-Users 2021–2027 ($ million)
Exhibit 60 Incremental Growth by Geography 2021 & 2027
Exhibit 61 Global AI in Genomics Market by Geography
Exhibit 62 Global AI in Genomics Market by Geography: Incremental Growth
Exhibit 63 Global AI in Genomics Market by Geography: Absolute Growth
Exhibit 64 North America AI in Genomics Market: Incremental & Absolute Growth
Exhibit 65 North America AI in Genomics Market: Key Countries 2021
Exhibit 66 North America AI in Genomics Market 2021–2027 ($ million)
Exhibit 67 Incremental Growth in North America 2021 & 2027
Exhibit 68 Use of AI in Healthcare Applications in US-2020 (%)
Exhibit 69 AI in Genomics Market in US 2021–2027 ($ million)
Exhibit 70 AI in Genomics Market in Canada 2021–2027 ($ million)
Exhibit 71 Europe AI in Genomics Market: Incremental & Absolute Growth
Exhibit 72 Europe AI in Genomics Market: Key Countries 2021
Exhibit 73 Europe AI in Genomics Market 2021–2027 ($ million)
Exhibit 74 Incremental Growth in Europe 2021 & 2027
Exhibit 75 AI in Genomics Market in Germany 2021–2027 ($ million)
Exhibit 76 AI in Genomics Market in UK 2021–2027 ($ million)
Exhibit 77 AI in Genomics Market in France 2021–2027 ($ million)
Exhibit 78 AI in Genomics Market in Italy 2021–2027 ($ million)
Exhibit 79 AI in Genomics Market in Spain 2021–2027 ($ million)
Exhibit 80 APAC AI in Genomics Market: Incremental & Absolute Growth
Exhibit 81 APAC AI in Genomics Market: Key Countries 2021
Exhibit 82 APAC AI in Genomics Market 2021–2027 ($ million)
Exhibit 83 Incremental Growth in APAC 2021 & 2027
Exhibit 84 AI in Genomics Market in Japan 2021–2027 ($ million)
Exhibit 85 AI in Genomics Market in China 2021–2027 ($ million)
Exhibit 86 AI in Genomics Market in India 2021–2027 ($ million)
Exhibit 87 AI in Genomics Market in Australia 2021–2027 ($ million)
Exhibit 88 AI in Genomics Market in South Korea 2021–2027 ($ million)
Exhibit 89 Latin America AI in Genomics Market: Incremental & Absolute Growth
Exhibit 90 Latin America AI in Genomics Market: Key Countries 2021
Exhibit 91 Latin America AI in Genomics Market 2021–2027 ($ million)
Exhibit 92 Incremental Growth in Latin America 2021 & 2027
Exhibit 93 AI in Genomics Market in Brazil 2021–2027 ($ million)
Exhibit 94 AI in Genomics Market in Mexico 2021–2027 ($ million)
Exhibit 95 Middle East & Africa AI in Genomics Market: Incremental & Absolute Growth
Exhibit 96 Middle East & Africa AI in Genomics Market: Key Countries 2021
Exhibit 97 Middle East & Africa AI in Genomics Market 2021–2027 ($ million)
Exhibit 98 Incremental Growth in Middle East & Africa 2021 & 2027
Exhibit 99 AI in Genomics Market in Turkey 2021–2027 ($ million)
Exhibit 100 AI in Genomics Market in Saudi Arabia 2021–2027 ($ million)
Exhibit 101 AI in Genomics Market in South Africa 2021–2027 ($ million)
Exhibit 102 International Business Machines: Annual Revenue 2018-2020 ($ million)
Exhibit 103 International Business Machines Corporation.: Annual Revenue 2018-2020 ($ million)
Exhibit 104 Microsoft: Annul Revenue 2018-2020 ($ million)
Exhibit 105 Microsoft Corporation: R&D Spending 2018-2020 ($ million)
Exhibit 106 NVIDIA: Annual Revenue 2018-2020 ($ million)
Exhibit 107 NVIDIA: R&D Spending 2018-2020 ($ million)

LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2015−2021
Table 3 Global On-Premises AI in Genomics Market by Geography 2021−2027 ($ million)
Table 4 Global On-Premises AI in Genomics Market by Geography 2021−2027 (%)
Table 5 Global Cloud-Based AI in Genomics Market by Geography 2021−2027 ($ million)
Table 6 Global Cloud-Based AI in Genomics Market by Geography 2021−2027 (%)
Table 7 Global AI in Genome Sequencing Market by Geography 2021−2027 ($ million)
Table 8 Global AI in Genome Sequencing Market by Geography 2021−2027 (% share)
Table 9 Global AI in Genomics Market by Gene Editing: Geography 2021−2027 ($ million)
Table 10 Global AI in Genomics Market by Gene Editing: Geography 2021−2027 (%)
Table 11 Global AI in Genomics Market by Other Functionality: Geography 2021−2027 ($ million)
Table 12 Global AI in Genomics Market by Other Functionality: Geography 2021−2027 (%)
Table 13 Global AI in Genomics Market by Translational Precision Medicine: Geography 2021−2027 ($ million)
Table 14 Global AI in Genomics Market by Translational Precision Medicine: Geography 2021−2027 (%)
Table 15 Global AI in Genomics Market by Clinical & Genomic Diagnosis: Geography 2021−2027 ($ million)
Table 16 Global AI in Genomics Market by Clinical & Genomic Diagnosis: Geography 2021−2027 (%)
Table 17 Global AI in Genomics Market by Other Applications: Geography 2021−2027 ($ million)
Table 18 Global AI in Genomics Market by Other Applications: Geography 2021−2027 (%)
Table 19 Global AI in Genomics Market by Pharma & Biotech Companies: Geography 2021−2027 ($ million)
Table 20 Global AI in Genomics Market by Pharma & Biotech Companies: Geography 2021−2027 (%)
Table 21 Global AI in Genomics Market by Public & Consumer Genomic Centers: Geography 2021−2027 ($ million)
Table 22 Global AI in Genomics Market by Public & Consumer Genomic Centers: Geography 2021−2027 (%)
Table 23 Global AI in Genomics Market by Other End-Users: Geography 2021−2027 ($ million)
Table 24 Global AI in Genomics Market by Other End-Users: Geography 2021−2027 (%)
Table 25 North America AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 26 North America AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 27 North America AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 28 North America AI in Genomics Market by Functionality 2021−2027 (%)
Table 29 North America AI in Genomics Market by Application 2021−2027 ($ million)
Table 30 North America AI in Genomics Market by Application 2021−2027 (%)
Table 31 North America AI in Genomics Market by End-User 2021−2027 ($ million)
Table 32 North America AI in Genomics Market by End-User 2021−2027 (%)
Table 33 Europe AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 34 Europe AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 35 Europe AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 36 Europe AI in Genomics Market by Functionality 2021−2027 (%)
Table 37 Europe AI in Genomics Market by Application 2021−2027 ($ million)
Table 38 Europe AI in Genomics Market by Application 2021−2027 (%)
Table 39 AI in Genomics Market in Europe by End-User 2021−2027 ($ million)
Table 40 AI in Genomics Market in Europe by End-User 2021−2027 (%)
Table 41 APAC AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 42 APAC AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 43 APAC AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 44 APAC AI in Genomics Market by Functionality 2021−2027 (%)
Table 45 APAC AI in Genomics Market by Application 2021−2027 ($ million)
Table 46 APAC AI in Genomics Market by Application 2021−2027 (%)
Table 47 APAC AI in Genomics Market by End-User 2021−2027 ($ million)
Table 48 APAC AI in Genomics Market by End-User 2021−2027 (%)
Table 49 AI in Genomics Market in Latin America by Delivery Mode 2021−2027 ($ million)
Table 50 AI in Genomics Market in Latin America by Delivery Mode 2021−2027 (%)
Table 51 Latin America AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 52 Latin America AI in Genomics Market by Functionality 2021−2027 (%)
Table 53 Latin America AI in Genomics Market by Application 2021−2027 ($ million)
Table 54 Latin America AI in Genomics Market by Application 2021−2027 (%)
Table 55 Latin America AI in Genomics Market by End-User 2021−2027 ($ million)
Table 56 AI in Genomics Market in Latin America by End-User 2021−2027 (%)
Table 57 Middle East & Africa AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 58 Middle East & Africa AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 59 Middle East & Africa AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 60 Middle East & Africa AI in Genomics Market by Functionality 2021−2027 (%)
Table 61 Middle East & Africa AI in Genomics Market by Application 2021−2027 ($ million)
Table 62 Middle East & Africa AI in Genomics Market by Application 2021−2027 (%)
Table 63 Middle East & Africa AI in Genomics Market by End-User 2021−2027 ($ million)
Table 64 Middle East & Africa AI in Genomics Market by End-User 2021−2027 (%)
Table 65 Fabric Genomics: Major Product Offerings
Table 66 International Business Machines Corporation: Major Product Offerings
Table 67 Microsoft: Major Product Offerings
Table 68 NVIDIA: Major Product Offerings
Table 69 AI Therapeutics: Major Product Offerings
Table 70 Ares Genetics: Major Product Offerings
Table 71 BenevolentAI: Major Product Offerings
Table 72 Deep Genomics: Major Product Offerings
Table 73 Diploid: Major Product Offerings
Table 74 DNAnexus: Major Product Offerings
Table 75 Emedgene: Major Product Offerings
Table 76 Empiric Logic: Major Product Offerings
Table 77 Engine Biosciences: Major Product Offerings
Table 78 FDNA: Major Product Offerings
Table 79 Freenome Holdings: Major Product Offerings
Table 80 Genuity Science: Major Product Offerings
Table 81 Lifebit: Major Product Offerings
Table 82 MolecularMatch: Major Product Offerings
Table 83 Predictive Oncology: Major Product Offerings
Table 84 SOPHiA GENETICS: Major Product Offerings
Table 85 Verge Genomics: Major Product Offerings
Table 86 WhiteLab Genomics: Major Product Offerings
Table 87 Global AI in Genomics Market by Geography 2021−2027 ($ million)
Table 88 Global AI in Genomics Market by Geography 2021−2027 (%)
Table 89 North America AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 90 North America AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 91 North America AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 92 North America AI in Genomics Market by Functionality 2021−2027 (%)
Table 93 North America AI in Genomics Market by Application 2021−2027 ($ million)
Table 94 North America AI in Genomics Market by Application 2021−2027 (%)
Table 95 North America AI in Genomics Market by End-User 2021−2027 ($ million)
Table 96 North America AI in Genomics Market by End-User 2021−2027 (%)
Table 97 Europe AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 98 Europe AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 99 Europe AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 100 Europe AI in Genomics Market by Functionality 2021−2027 (%)
Table 101 Europe AI in Genomics Market by Application 2021−2027 ($ million)
Table 102 Europe AI in Genomics Market by Application 2021−2027 (%)
Table 103 Europe AI in Genomics Market by End-User 2021−2027 ($ million)
Table 104 Europe AI in Genomics Market by End-User 2021−2027 (%)
Table 105 APAC AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 106 APAC AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 107 APAC AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 108 APAC AI in Genomics Market by Functionality 2021−2027 (%)
Table 109 APAC AI in Genomics Market by Application 2021−2027 ($ million)
Table 110 APAC AI in Genomics Market by Application 2021−2027 (%)
Table 111 APAC AI in Genomics Market by End-User 2021−2027 ($ million)
Table 112 APAC AI in Genomics Market by End-User 2021−2027 (%)
Table 113 Latin America AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 114 Latin America AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 115 Latin America AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 116 Latin America AI in Genomics Market by Functionality 2021−2027 (%)
Table 117 Latin America AI in Genomics Market by Application 2021−2027 ($ million)
Table 118 Latin America AI in Genomics Market by Application 2021−2027 (%)
Table 119 AI in Genomics Market in Latin America by End-User 2021−2027 ($ million)
Table 120 AI in Genomics Market in Latin America by End-User 2021−2027 (%)
Table 121 Middle East & Africa AI in Genomics Market by Delivery Mode 2021−2027 ($ million)
Table 122 Middle East & Africa AI in Genomics Market by Delivery Mode 2021−2027 (%)
Table 123 Middle East & Africa AI in Genomics Market by Functionality 2021−2027 ($ million)
Table 124 Middle East & Africa AI in Genomics Market by Functionality 2021−2027 (%)
Table 125 Middle East & Africa AI in Genomics Market by Application 2021−2027 ($ million)
Table 126 Middle East & Africa AI in Genomics Market by Application 2021−2027 (%)
Table 127 Middle East & Africa AI in Genomics Market by End-User 2021−2027 ($ million)
Table 128 Middle East & Africa AI in Genomics Market by End-User 2021−2027 (%)
Table 129 Global AI in Genomics Market by On-Premises: Geography 2021−2027 ($ million)
Table 130 Global AI in Genomics Market by On-Premises: Geography 2021−2027 (%)
Table 131 Global AI in Genomics Market by Cloud-Based: Geography 2021−2027 ($ million)
Table 132 Global AI in Genomics Market by Cloud-Based: Geography 2021−2027 (%)
Table 133 Global AI in Genomics Market by Genome Sequencing: Geography 2021−2027 ($ million)
Table 134 Global AI in Genomics Market by Genome Sequencing: Geography 2021−2027 (%)
Table 135 Global AI in Genomics Market by Gene Editing: Geography 2021−2027 ($ million)
Table 136 Global AI in Genomics Market by Gene Editing: Geography 2021−2027 (%)
Table 137 Global AI in Genomics Market by Other Functionality: Geography 2021−2027 ($ million)
Table 138 Global AI in Genomics Market by Other Functionality: Geography 2021−2027 (%)
Table 139 Global AI in Genomics Market by Translational Precision Medicine: Geography 2021−2027 ($ million)
Table 140 Global AI in Genomics Market by Translational Precision Medicine: Geography 2021−2027 (%)
Table 141 Global AI in Genomics Market by Clinical & Genomic Diagnostics: Geography 2021−2027 ($ million)
Table 142 Global AI in Genomics Market by Clinical & Genomic Diagnostics: Geography 2021−2027 (%)
Table 143 Global AI in Genomics Market by Other Applications: Geography 2021−2027 (%)
Table 144 Global AI in Genomics Market by Pharma & Biotech Companies: Geography 2021−2027 ($ million)
Table 145 Global AI in Genomics Market by Pharma & Biotech Companies: Geography 2021−2027 (%)
Table 146 Global AI in Genomics Market by Public & Consumer Genomic Centers: Geography 2021−2027 ($ million)
Table 147 Global AI in Genomics Market by Public & Consumer Genomic Centers: Geography 2021−2027 (%)
Table 148 Global AI in Genomics Market by Other End-Users: Geography 2021−2027 ($ million)
Table 149 Global AI in Genomics Market by Other End-Users: Geography 2021−2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date